5.52 USD
↗ 0.00 (0.00%)PRE MARKET (AS OF 07:54 PM EDT)
Aardvark Therapeutics, Inc. Common Stock
AARDNASDAQ • USD
Market: OPEN
Open?$5.40
High?$5.66
Low?$5.30
Prev. Close?$5.52
Volume?105.4K
Avg. Volume?229.7K
VWAP?$5.51
Rel. Volume?0.46x
Bid / Ask
Bid?$4.47 × 100
Ask?$6.27 × 100
Spread?$1.80
Midpoint?$5.37
Valuation & Ratios
Market Cap?120.4M
Shares Out?21.8M
Float?11.0M
Float %?50.6%
P/E Ratio?N/A
P/B Ratio?1.13
EPS?-$2.64
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?10.61Strong
Quick Ratio?10.61Strong
Cash Ratio?4.46Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?1.13CHEAP▾
P/S?102.49HIGH▾
P/FCF?N/A▾
EV/EBITDA?-1.2CHEAP▾
EV/Sales?62.45HIGH▾
Returns & Efficiency
ROE?-54.0%WEAK▾
ROA?-49.2%WEAK▾
Cash Flow & Enterprise
FCF?$-54267000
Enterprise Value?$73.4M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
Employees
40
Market Cap
117.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2025-02-13
Address
4370 LA JOLLA VILLAGE DRIVE
SAN DIEGO, CA 92122
Phone: (858) 225-7696
SAN DIEGO, CA 92122
Phone: (858) 225-7696